Free Trial

Aldeyra Therapeutics (ALDX) Competitors

Aldeyra Therapeutics logo
$5.81 -0.07 (-1.19%)
Closing price 04:00 PM Eastern
Extended Trading
$5.76 -0.04 (-0.77%)
As of 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ALDX vs. PAHC, XERS, CVAC, ELVN, CALT, COLL, NTLA, PHVS, GPCR, and TLRY

Should you be buying Aldeyra Therapeutics stock or one of its competitors? The main competitors of Aldeyra Therapeutics include Phibro Animal Health (PAHC), Xeris Biopharma (XERS), CureVac (CVAC), Enliven Therapeutics (ELVN), Calliditas Therapeutics AB (publ) (CALT), Collegium Pharmaceutical (COLL), Intellia Therapeutics (NTLA), Pharvaris (PHVS), Structure Therapeutics (GPCR), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

Aldeyra Therapeutics vs. Its Competitors

Phibro Animal Health (NASDAQ:PAHC) and Aldeyra Therapeutics (NASDAQ:ALDX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

In the previous week, Phibro Animal Health had 9 more articles in the media than Aldeyra Therapeutics. MarketBeat recorded 14 mentions for Phibro Animal Health and 5 mentions for Aldeyra Therapeutics. Phibro Animal Health's average media sentiment score of 0.65 beat Aldeyra Therapeutics' score of 0.49 indicating that Phibro Animal Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Phibro Animal Health
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aldeyra Therapeutics
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Phibro Animal Health presently has a consensus price target of $24.40, suggesting a potential downside of 24.83%. Aldeyra Therapeutics has a consensus price target of $9.50, suggesting a potential upside of 63.51%. Given Aldeyra Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Aldeyra Therapeutics is more favorable than Phibro Animal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Phibro Animal Health
2 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.83
Aldeyra Therapeutics
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Phibro Animal Health has higher revenue and earnings than Aldeyra Therapeutics. Aldeyra Therapeutics is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Phibro Animal Health$1.19B1.11$2.42M$0.7841.62
Aldeyra TherapeuticsN/AN/A-$55.85M-$0.85-6.84

Phibro Animal Health has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, Aldeyra Therapeutics has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500.

99.3% of Phibro Animal Health shares are held by institutional investors. Comparatively, 59.7% of Aldeyra Therapeutics shares are held by institutional investors. 50.1% of Phibro Animal Health shares are held by insiders. Comparatively, 9.6% of Aldeyra Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Phibro Animal Health has a net margin of 2.68% compared to Aldeyra Therapeutics' net margin of 0.00%. Phibro Animal Health's return on equity of 30.51% beat Aldeyra Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Phibro Animal Health2.68% 30.51% 6.89%
Aldeyra Therapeutics N/A -73.63%-50.61%

Summary

Phibro Animal Health beats Aldeyra Therapeutics on 12 of the 15 factors compared between the two stocks.

Get Aldeyra Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALDX vs. The Competition

MetricAldeyra TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$348.02M$2.80B$5.82B$9.73B
Dividend YieldN/A1.66%3.84%4.09%
P/E Ratio-6.8422.6131.1525.96
Price / SalesN/A751.86475.15122.97
Price / CashN/A173.2237.1558.38
Price / Book6.325.869.116.39
Net Income-$55.85M$31.83M$3.26B$265.56M
7 Day Performance7.79%1.80%2.11%1.98%
1 Month Performance8.40%4.36%5.12%1.33%
1 Year Performance11.09%11.44%31.25%21.15%

Aldeyra Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALDX
Aldeyra Therapeutics
2.1231 of 5 stars
$5.81
-1.2%
$9.50
+63.5%
+9.7%$348.02MN/A-6.8410
PAHC
Phibro Animal Health
3.6202 of 5 stars
$31.25
+1.9%
$24.40
-21.9%
+70.9%$1.24B$1.19B40.061,940News Coverage
Upcoming Earnings
Analyst Revision
XERS
Xeris Biopharma
3.4866 of 5 stars
$7.36
-4.2%
$6.58
-10.6%
+167.3%$1.24B$203.07M-35.05290News Coverage
Positive News
Analyst Forecast
Analyst Revision
CVAC
CureVac
4.7153 of 5 stars
$5.45
-0.5%
$6.83
+25.4%
+63.3%$1.23B$579.18M5.92880News Coverage
Earnings Report
Short Interest ↓
ELVN
Enliven Therapeutics
2.9087 of 5 stars
$19.75
-2.3%
$41.20
+108.6%
-16.2%$1.20BN/A-9.8850Insider Trade
CALT
Calliditas Therapeutics AB (publ)
N/A$40.00
flat
N/AN/A$1.19B$1.60B-21.62180
COLL
Collegium Pharmaceutical
2.2186 of 5 stars
$38.19
+1.2%
$42.33
+10.8%
+10.9%$1.19B$631.45M36.72210News Coverage
Insider Trade
NTLA
Intellia Therapeutics
4.5758 of 5 stars
$10.73
-2.4%
$29.05
+170.8%
-57.1%$1.18B$57.88M-2.29600
PHVS
Pharvaris
2.6963 of 5 stars
$22.16
-0.6%
$35.60
+60.6%
+31.3%$1.17BN/A-6.6030
GPCR
Structure Therapeutics
2.4964 of 5 stars
$19.96
-0.8%
$75.71
+279.3%
-51.1%$1.16BN/A-19.01136
TLRY
Tilray Brands
2.5039 of 5 stars
$1.14
+10.7%
$1.92
+68.1%
-41.3%$1.13B$821.31M-0.492,842

Related Companies and Tools


This page (NASDAQ:ALDX) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners